Status
Conditions
Treatments
About
This is a prospective, multicenter, cohort study aims to demonstrate the role of termination of AF in ablation for persistent atrial fibrillation, and evaluate the clinical outcomes in patients with or without AF termination.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
With uncontrolled congestive heart failure;
Having significant valvular disease and/or prosthetic heart valve(s);
With myocardial infarction or stroke within 6 months of screening;
With Significant congenital heart disease;
Ejection fraction was <40% measured by echocardiography;
Allergic to contrast media;
Contraindication to anticoagulation medications;
Severe pulmonary disease e.g. restrictive pulmonary disease, chronic obstructive disease (COPD);
Left atrial (LA) thrombus measured by pre-procedure transesophageal echocardiography;
Having any contraindication to right or left sided heart catheterization; 11. Previous atrial fibrillation ablation;
Presence of an implanted cardioverter-defibrillator; 13. Any cardiac surgery within the past 2 months; 14. Poor general health; 15.Life expectancy less than 6 months.
400 participants in 1 patient group
Loading...
Central trial contact
Qin Mu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal